Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three ...

The global surface plasmon resonance (SPR) system market is on a steady growth trajectory, with a projected valuation of USD ...

The United States market has been flat over the last week but is up 21% over the past year, with earnings forecast to grow by 14% annually. In this environment, identifying high growth tech stocks ...